BioSpace News Archive

BioSTL has won a $1.5 million grant from the Economic Development Administration (EDA) of the U.S. Department of Commerce to launch a new Center for Defense Medicine in St. Louis.

Precision Optics Corporation, Inc. announced that it has scheduled a conference call to discuss fourth quarter and fiscal year 2020 financial results on Thursday, September 24, 2020 at 5:00pm ET.

Geron Corporation reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company.

Shanghai ChemPartner announced today the appointment of Steven Yu , Ph.D. as Vice President of Regulated Bioanalysis at the company headquarters in Shanghai, China . Dr. Yu has more than 15 years of experience in drug development and extensive expertise in assay development and validation, biomarker development, immunogenicity

ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, today introduces the industry’s thinnest dedicated sensor for blood oxygen saturation (SpO2) measurement, bringing the capability to remotely monitor this vital sign to small consumer products such as earbuds, smart watches and wristbands, as well as to medical devices such as patches and oximeters

NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that Deputy Secretary of Energy Mark W. Menezes visited the Company’s Beloit, Wis. headquarters on September 11, 2020.

Valent BioSciences LLC officially moved its global Biorational Headquarters (BHQ) to Innovation Park in Libertyville, Ill. The new headquarters is situated in the same complex as the more than 90,000-square-foot Biorational Research Center (BRC), which relocated from Long Grove, Ill., in 20

Deloitte has appointed Tina Wheeler as national sector leader for the health care practice in the U.S. effective immediately. Wheeler, a partner with Deloitte & Touche

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. This marks the 387 th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 16, 2020, to shareholders of record at the close of business on Oct. 15, 2020 . Abbott h

Steven Zelenkofske appointed chairman to provide expertise in heart failure clinical development. [17-September-2020] INDIANAPOLIS , Sept. 17, 2020 /PRNewswire/ -- FAST BioMedical , a late clinical-stage medical technology company, today announces establishing a Heart Failure Medical Advisory Board of world-recognized physicians, nurses and researchers. The Board w